Rapid Communication| Volume 48, ISSUE 4, e29-e32, April 2013

Spontaneous rupture of an advanced pancreatoblastoma: Aberrant RASSF1A methylation and CTNNB1 mutation as molecular genetic markers


      Pancreatoblastoma is a rare pancreatic tumor that is most commonly encountered in infants and young children. This report describes an unusual presentation of a large pancreatic body pancreatoblastoma presenting with intraabdominal bleeding due to spontaneous rupture of the tumor in a 5-year-old boy. Subsequent molecular analysis from the resected specimen identified a mutation in CTNNB1 and aberrant methylation of the tumor suppressor RASSF1A.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dhebri A.R.
        • Connor S.
        • Campbell F.
        • et al.
        Diagnosis, treatment and outcome of pancreatoblastoma.
        Pancreatology. 2004; 4: 441-451
        • Bien E.
        • Godzinski J.
        • Dall'igna P.
        • et al.
        Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT).
        Eur J Cancer. 2011; 47: 2347-2352
        • Abraham S.C.
        • Wu T.T.
        • Klimstra D.S.
        • et al.
        Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
        Am J Pathol. 2001; 159: 1619-1627
        • Gu W.Z.
        • Zou C.C.
        • Zhao Z.Y.
        • et al.
        Childhood pancreatoblastoma: clinical features and immunohistochemistry analysis.
        Cancer Lett. 2008; 264: 119-126
        • Kerr N.J.
        • Chun Y.H.
        • Yun K.
        • et al.
        Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression.
        Med Pediatr Oncol. 2002; 39: 52-54
        • Koch A.
        • Denkhaus D.
        • Albrecht S.
        • et al.
        Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
        Cancer Res. 1999; 59: 269-273
        • Honda S.
        • Haruta M.
        • Sugawara W.
        • et al.
        The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.
        Int J Cancer. 2008; 123: 1117-1125
        • Cairo S.
        • Armengol C.
        • Reynies A.D.
        • et al.
        Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.
        Cancer Cell. 2008; 14: 471-484
        • Agathanggelou A.
        • Cooper W.N.
        • Latif F.
        • et al.
        Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.
        Cancer Res. 2005; 65: 3497-3508
        • Wong I.H.N.
        • Chan J.
        • Wong J.
        • et al.
        Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia.
        Clin Cancer Res. 2004; 10: 994-1002